Deborah M. Autor - Jul 29, 2022 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role
Director
Signature
/s/ Jason B. Daly, Attorney-in-Fact
Stock symbol
AMRX
Transactions as of
Jul 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/2/2022, 09:26 PM
Previous filing
Jun 10, 2022
Next filing
May 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRX Restricted Stock Units Award $0 +54.9K $0.00 54.9K Jul 29, 2022 Class A Common Stock 54.9K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 Restricted stock units vest on the later of (i) the day immediately preceding the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant.